Santanen U, Rautoma P, Luurila H, Erkola O
The Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Finland.
Ann Chir Gynaecol. 2001;90(1):47-50.
To evaluate the effect of intra-articular ropivacaine injection on postoperative knee pain after day case arthroscopy.
We studied one hundred outpatients in a prospective, randomized, double-blind fashion to examine the postoperative analgesic effect of intra-articular ropivacaine or saline injected into the knee joint after day-case knee arthroscopy performed under spinal anaesthesia. Patients were interviewed postoperatively with a standardized questionnaire. The postoperative pain was measured using a 100-mm visual analogue scale (VAS).
There were no statistically significant differences in the VAS scores of knee pain eight hours or more after the operation between the intra-articular ropivacaine and saline groups, and there was no significant difference in the need for postoperative pain killer.
This study failed to demonstrate a decrease in postoperative VAS scores at eight hours and later postoperatively when 20 ml of ropivacaine 0.5% were injected intra-articularly after day-case knee arthroscopy performed under spinal anaesthesia. Furthermore, there was no significant difference in the need for postoperative pain medication between the study groups.
评估关节腔内注射罗哌卡因对日间手术关节镜检查术后膝关节疼痛的影响。
我们以前瞻性、随机、双盲的方式研究了100例门诊患者,以检查在脊髓麻醉下进行日间膝关节镜检查后,关节腔内注射罗哌卡因或生理盐水的术后镇痛效果。术后用标准化问卷对患者进行访谈。术后疼痛采用100毫米视觉模拟量表(VAS)进行测量。
关节腔内注射罗哌卡因组和生理盐水组术后8小时及更长时间的膝关节疼痛VAS评分无统计学显著差异,术后使用止痛剂的需求也无显著差异。
本研究未能证明在脊髓麻醉下进行日间膝关节镜检查后,关节腔内注射20毫升0.5%罗哌卡因可使术后8小时及以后的VAS评分降低。此外,研究组之间术后止痛药物的需求无显著差异。